s6y
Company name or ticker
Search
Clover Biopharmaceuticals, Ltd.
D
Exempt (Private) Offering
Filed
Wednesday, April 29, 2026
Accession number
0001856491-26-000003
Documents
primary_doc.xml
D
On sec.gov
Filing index
All files
Complete submission text
SGML header